ACHC · Acadia Healthcare Company, Inc. · Proposed Sales
$38.17
+0.39 (+1.03%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$3.51B
Shares
92.97M
Volume · Nov 16
333.99K
Avg daily vol (3M)
1.82M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-08-30 | Hollinsworth John S. | Officer | 20,000 | 2024-08-30 | Merrill Lynch |
| 2024-08-29 | Hollinsworth John S. | Officer | 10,000 | 2024-08-29 | Merrill Lynch |
| 2024-08-08 | Hollinsworth John S. | Officer | 5,000 | 2024-08-08 | Merrill Lynch |
| 2024-03-08 | Miquelon Wade D | Director | 2,203 | 2024-03-05 | Raymond James & Associates, Inc. |
| 2024-03-04 | Gregg Vicky B | Officer | 2,500 | 2024-03-04 | Merrill Lynch |
| 2023-11-15 | Hollinsworth John S. | Officer | 47,500 | 2023-11-15 | Merrill Lynch/Chris Mitchell |
| 2023-11-14 | Hollinsworth John S. | Officer | 45,000 | 2023-11-14 | Merrill Lynch/Chris Mitchell |
| 2023-11-13 | Hollinsworth John S. | Officer | 20,000 | 2023-11-10 | Merrill Lynch/ Chris Mitchell |
| 2023-11-08 | Hollinsworth John S. | Officer | 12,500 | 2023-11-08 | Merrill Lynch/Chris Mitchell |
Showing 1–9 of 9 filings
Key facts
CIK
1520697
CUSIP
00404A109
13F (30d)
215 filings
194 filers
Visit website
Investor relations